Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $590 - $769
-15 Reduced 0.26%
5,729 $233,000
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $501 - $654
-12 Reduced 0.21%
5,744 $294,000
Q3 2022

Oct 31, 2022

BUY
$43.76 - $53.42 $26,868 - $32,799
614 Added 11.94%
5,756 $251,000
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $239,257 - $283,684
5,142 New
5,142 $269,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $225,135 - $278,971
-4,921 Closed
0 $0
Q4 2021

Apr 08, 2022

BUY
$41.32 - $61.25 $194,038 - $287,630
4,696 Added 2087.11%
4,921 $290,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $9,297 - $13,781
225 New
225 $290,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Baltimore Washington Financial Advisors, Inc. Portfolio

Follow Baltimore Washington Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baltimore Washington Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baltimore Washington Financial Advisors, Inc. with notifications on news.